DrugPatentWatch Database Preview
Drugs in Development Information for Pyridoxamine
» See Plans and Pricing
What is the development status for investigational drug Pyridoxamine?
Pyridoxamine is an investigational drug.
There have been 6 clinical trials for Pyridoxamine.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2014.
The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Nephrolithiasis. The leading clinical trial sponsors are Collaborative Study Group (CSG), BioStratum, and NephroGenex, Inc.
There is one US patent protecting this investigational drug and nine international patents.
Summary for Pyridoxamine
| US Patents | 1,012 |
| International Patents | 9,642 |
| US Patent Applications | 2,033 |
| WIPO Patent Applications | 2,287 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 2 (2014-06-01) |
| Vendors | 38 |
Recent Clinical Trials for Pyridoxamine
| Title | Sponsor | Phase |
|---|---|---|
| Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine | Columbia University | N/A |
| Pyridorin in Diabetic Nephropathy | Collaborative Study Group (CSG) | Phase 3 |
| Pyridorin in Diabetic Nephropathy | Medpace, Inc. | Phase 3 |
Clinical Trial Summary for Pyridoxamine
Top disease conditions for Pyridoxamine
Top clinical trial sponsors for Pyridoxamine
US Patents for Pyridoxamine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Pyridoxamine | Start Trial | Particle detecting device | AZBIL CORPORATION (Chiyoda-ku, JP) | Start Trial |
| Pyridoxamine | Start Trial | Compositions and methods useful for ameliorating age related maladies | NestecSA (Vevey, CH) | Start Trial |
| Pyridoxamine | Start Trial | Fused heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Pyridoxamine | Start Trial | Heterocyclic compound | Takeda Pharmaceutical Company Limited (Tokyo, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Pyridoxamine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Pyridoxamine | Japan | JP2015224973 | 2034-05-28 | Start Trial |
| Pyridoxamine | Japan | JP6456605 | 2034-05-28 | Start Trial |
| Pyridoxamine | Australia | AU2012231351 | 2031-03-18 | Start Trial |
| Pyridoxamine | Brazil | BR112013023770 | 2031-03-18 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
